Sure, there are a lot of transcatheter valves around, each with strengths and weaknesses. But if the trials show that this valve is easy to position, stays in place, is durable and has haemodynamic performance that is as good or better than the competition then it has the potential to become the market leader.
- Forums
- ASX - By Stock
- Anteris Channel 9 Interview 2022
AVR
anteris technologies global corp.
Add to My Watchlist
6.43%
!
$6.29

Sure, there are a lot of transcatheter valves around, each with...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$6.29 |
Change
0.380(6.43%) |
Mkt cap ! $97.48M |
Open | High | Low | Value | Volume |
$5.93 | $6.29 | $5.91 | $77.22K | 12.46K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 300 | $6.17 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$6.23 | 159 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 300 | 6.170 |
2 | 1447 | 6.150 |
1 | 3500 | 6.120 |
1 | 2000 | 6.100 |
1 | 1000 | 6.000 |
Price($) | Vol. | No. |
---|---|---|
6.230 | 159 | 1 |
6.280 | 1010 | 1 |
6.290 | 1424 | 1 |
6.300 | 1000 | 1 |
6.360 | 10 | 1 |
Last trade - 13.43pm 27/06/2025 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online